Combined treatment of rapamycin and dietary restriction has a larger effect on the transcriptome and metabolome of liver

Rapamycin (Rapa) and dietary restriction (DR) have consistently been shown to increase lifespan. To investigate whether Rapa and DR affect similar pathways in mice, we compared the effects of feeding mice ad libitum (AL), Rapa, DR, or a combination of Rapa and DR (Rapa + DR) on the transcriptome and metabolome of the liver. The principal component analysis shows that Rapa and DR are distinct groups. Over 2500 genes are significantly changed with either Rapa or DR when compared with mice fed AL; more than 80% are unique to DR or Rapa. A similar observation was made when genes were grouped into pathways; two‐thirds of the pathways were uniquely changed by DR or Rapa. The metabolome shows an even greater difference between Rapa and DR; no metabolites in Rapa‐treated mice were changed significantly from AL mice, whereas 173 metabolites were changed in the DR mice. Interestingly, the number of genes significantly changed by Rapa + DR when compared with AL is twice as large as the number of genes significantly altered by either DR or Rapa alone. In summary, the global effects of DR or Rapa on the liver are quite different and a combination of Rapa and DR results in alterations in a large number of genes and metabolites that are not significantly changed by either manipulation alone, suggesting that a combination of DR and Rapa would be more effective in extending longevity than either treatment alone.

[1]  S. Austad,et al.  Rapamycin extends life and health in C57BL/6 mice. , 2014, The journals of gerontology. Series A, Biological sciences and medical sciences.

[2]  H. Fuchs,et al.  Rapamycin extends murine lifespan but has limited effects on aging. , 2013, The Journal of clinical investigation.

[3]  Hong-Mei Zhang,et al.  Dietary restriction attenuates the accelerated aging phenotype of Sod1(-/-) mice. , 2013, Free radical biology & medicine.

[4]  Dean P. Jones,et al.  Short-Term Treatment With Rapamycin and Dietary Restriction Have Overlapping and Distinctive Effects in Young Mice , 2012, The journals of gerontology. Series A, Biological sciences and medical sciences.

[5]  Daniel Wuttke,et al.  A meta-analysis of caloric restriction gene expression profiles to infer common signatures and regulatory mechanisms. , 2012, Molecular bioSystems.

[6]  Dudley Lamming,et al.  Rapamycin-Induced Insulin Resistance Is Mediated by mTORC2 Loss and Uncoupled from Longevity , 2012, Science.

[7]  A. Bartke,et al.  Rapamycin slows aging in mice , 2012, Cell cycle.

[8]  M. A. D. de Mello,et al.  Dietary restriction, caloric value and the accumulation of hepatic fat , 2012, Lipids in Health and Disease.

[9]  V. Anisimov,et al.  Rapamycin increases lifespan and inhibits spontaneous tumorigenesis in inbred female mice , 2011, Cell cycle.

[10]  Z. D. Sharp,et al.  Aging and cancer: can mTOR inhibitors kill two birds with one drug? , 2011, Targeted Oncology.

[11]  R. de Cabo,et al.  Rapamycin, but not resveratrol or simvastatin, extends life span of genetically heterogeneous mice. , 2011, The journals of gerontology. Series A, Biological sciences and medical sciences.

[12]  L. Partridge,et al.  Mechanisms of Life Span Extension by Rapamycin in the Fruit Fly Drosophila melanogaster , 2010, Cell metabolism.

[13]  B. Kennedy,et al.  Ageing: A midlife longevity drug? , 2009, Nature.

[14]  Marco Pahor,et al.  Rapamycin fed late in life extends lifespan in genetically heterogeneous mice , 2009, Nature.

[15]  A. Thomson,et al.  Immunoregulatory functions of mTOR inhibition , 2009, Nature Reviews Immunology.

[16]  C. Watson,et al.  A dual role for oncostatin M signaling in the differentiation and death of mammary epithelial cells in vivo. , 2008, Molecular endocrinology.

[17]  J. Rood,et al.  Effect of 6‐Month Calorie Restriction and Exercise on Serum and Liver Lipids and Markers of Liver Function , 2008, Obesity.

[18]  Joy W. Chang,et al.  Nrf2 mediates cancer protection but not prolongevity induced by caloric restriction , 2008, Proceedings of the National Academy of Sciences.

[19]  Z. Varghese,et al.  Sirolimus Modifies Cholesterol Homeostasis in Hepatic Cells: A Potential Molecular Mechanism for Sirolimus-Associated Dyslipidemia , 2007, Transplantation.

[20]  Seung-Jae V. Lee,et al.  Lifespan extension by conditions that inhibit translation in Caenorhabditis elegans , 2007, Aging cell.

[21]  J. Papaconstantinou,et al.  Identification of longevity-associated genes in long-lived Snell and Ames dwarf mice , 2006, AGE.

[22]  D. Sabatini,et al.  Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB. , 2006, Molecular cell.

[23]  Matt Kaeberlein,et al.  Extension of chronological life span in yeast by decreased TOR pathway signaling. , 2006, Genes & development.

[24]  J. Nelson,et al.  Housing density does not influence the longevity effect of calorie restriction. , 2005, The journals of gerontology. Series A, Biological sciences and medical sciences.

[25]  Matt Kaeberlein,et al.  Regulation of Yeast Replicative Life Span by TOR and Sch9 in Response to Nutrients , 2005, Science.

[26]  H. Blumenfeld.  Cellular and Network Mechanisms of Spike‐Wave Seizures , 2005, Epilepsia.

[27]  F. Matschinsky.  Glucokinase, glucose homeostasis, and diabetes mellitus , 2005, Current diabetes reports.

[28]  R. Weindruch,et al.  Long-term calorie restriction reduces proton leak and hydrogen peroxide production in liver mitochondria. , 2005, American journal of physiology. Endocrinology and metabolism.

[29]  J. Cidlowski,et al.  Mechanisms of glucocorticoid receptor signaling during inflammation , 2004, Mechanisms of Ageing and Development.

[30]  A. Bokov,et al.  The role of oxidative damage and stress in aging , 2004, Mechanisms of Ageing and Development.

[31]  N. Sonenberg,et al.  Upstream and downstream of mTOR. , 2004, Genes & development.

[32]  C. Thompson,et al.  Differential effects of rapamycin on mammalian target of rapamycin signaling functions in mammalian cells. , 2003, Cancer research.

[33]  J. Camardo,et al.  The Rapamune era of immunosuppression 2003: the journey from the laboratory to clinical transplantation. , 2003, Transplantation proceedings.

[34]  K. Becker,et al.  Analysis of microarray data using Z score transformation. , 2003, The Journal of molecular diagnostics : JMD.

[35]  P. Burkett,et al.  Regulation of lymphoid homeostasis by interleukin-15. , 2002, Cytokine & growth factor reviews.

[36]  Z. Kmieć,et al.  Cooperation of Liver Cells in Health and Disease , 2001, Advances in Anatomy Embryology and Cell Biology.

[37]  E. Bergamini,et al.  The protection of rat liver autophagic proteolysis from the age-related decline co-varies with the duration of anti-ageing food restriction , 2001, Experimental Gerontology.

[38]  A. Schmidt,et al.  Starvation Induces Vacuolar Targeting and Degradation of the Tryptophan Permease in Yeast , 1999, The Journal of cell biology.

[39]  J. French,et al.  Dietary restriction reduces insulin-like growth factor I levels, which modulates apoptosis, cell proliferation, and tumor progression in p53-deficient mice. , 1997, Cancer research.

[40]  M. Hall,et al.  The TOR signalling pathway and growth control in yeast. , 1996, Biochemical Society transactions.

[41]  Paul Tempst,et al.  RAFT1: A mammalian protein that binds to FKBP12 in a rapamycin-dependent fashion and is homologous to yeast TORs , 1994, Cell.

[42]  Stuart L. Schreiber,et al.  A mammalian protein targeted by G1-arresting rapamycin–receptor complex , 1994, Nature.

[43]  M. Mclaughlin,et al.  Yeast TOR (DRR) proteins: amino-acid sequence alignment and identification of structural motifs. , 1994, Gene.

[44]  A. Richardson,et al.  Effect of age and dietary restriction on the expression of alpha 2u-globulin. , 1987, The Journal of biological chemistry.

[45]  S. Das,et al.  Alterations of NADPH-generating and drug-metabolizing enzymes by feed restriction in male rats. , 1982, The Journal of nutrition.